Achelios Therapeutics

About Achelios Therapeutics

Achelios Therapeutics, established in 2012 in Chapel Hill, N.C., is a privately held, pharmaceutical-development company focused on developing topical drugs for the treatment of migraine and peripheral pain. It is backed by private capital financing, and its research has been supported in part by a Small Business Research Loan from the N.C. Biotechnology Center. The company’s name (Achelios) is derived from the mythological Greek moon goddess “Achelois,” which loosely translates as “she who washes away pain.”
YEAR FOUNDED:
2012
LEADERSHIP:
Founder and CEO: Crist J. Frangakis
CFO: Lucy Martindale
CMO: John Fort
CBO: Mike S Fox
JOBS:
Please click here for Achelios job opportunities.
PRODUCTS:
All Products